Endoplasmic Reticulum Stress Induces Tau Pathology and Forms a Vicious Cycle: Implication in Alzheimer's Disease Pathogenesis

Laboratory of Neurodegenerative Diseases, Department of Anatomy, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Journal of Alzheimer's disease: JAD (Impact Factor: 4.15). 11/2011; 28(4):839-54. DOI: 10.3233/JAD-2011-111037
Source: PubMed


Accumulation of unfolded proteins can disturb the functions of the endoplasmic reticulum (ER), leading to ER-stress or unfolded protein response (UPR). Recent data have shown that activation of UPR can be found in postmortem brains of Alzheimer's disease (AD) patients; and biological markers for activation of UPR are abundant in neurons with diffuse phosphorylated tau. Although these observations suggest a linkage between ER-stress and tau pathology, little is known of their relationship. In this study, we found that high levels of phosphorylated PKR-like ER-resident kinase (p-PERK) and phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α) as markers for activation of UPR in the hippocampus of aged P301L mutant tau transgenic mice. The immunoreactivity of p-PERK was found to co-localize with that of phosphorylated tau. We then hypothesized that phosphorylation of tau could induce ER-stress and vice versa in promoting AD-like pathogenesis. By using the protein phosphatase 2A inhibitor okadaic acid (OA) as an inducer for phosphorylation of tau, we found that primary cultures of rat cortical neurons treated with OA triggered UPR as indicated by increased levels of p-PERK and p-eIF2α, splicing of mRNA for xbp-1 and elevated levels of mRNA for GADD153. On the other hand, thapsigargin as an ER-stress inducer stimulated phosphorylation of tau at Thr231, Ser262 and Ser396. Thapsigargin also induced activation of caspase-3 and cleavage of tau. These findings suggested that ER-stress and hyperphosphorylation of tau could be induced by each other to form a vicious cycle to propagate AD-like neurodegeneration.

Download full-text


Available from: Larry Baum
  • Source
    • "Neurons are highly reliant on mitochondrial function since most neuronal ATP is generated through oxidative phosphorylation (Correia et al., 2012). The high-energy demand is dictated by numerous neuronal processes, including axonal transport of macromolecules and organelles, maintenance of membrane potential, buffering cytosolic Ca 2 + , and loading and releasing neurotransmitters into the synaptic cleft, a site distant from the soma (Saxton and Hollenbeck, 2012). These dynamic organelles are generated from the division of pre-existing organelles in the soma—a process called mitochondrial biogenesis—and have a particularly long half-life, increasing the probability of accumulating damage (DuBoff et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autophagy is a housekeeping process responsible for the bulk degradation of misfolded protein aggregates and damaged organelles through the lysosomal machinery. Given its key role as a cellular quality control mechanism, autophagy is now a focus of intense scrutiny in Alzheimer's disease (AD). The hallmarks of this devastating neurodegenerative disease are the accumulation of misfolded amyloid-β (Aβ) peptide and hyperphosphorylated tau protein and neuronal loss, which are accompanied by mitochondrial dysfunction and endoplasmic reticulum (ER) stress, suggesting that faulty autophagy is a contributing factor to AD pathology. Indeed, the AD brain is characterized by a massive accumulation of autophagic vacuoles within large swellings along dystrophic neurites and defects at different steps of the autophagic-lysosomal pathway. In this sense, this review provides an overview on the role of autophagy on Aβ metabolism, tau processing and clearance, and the contribution of ER-phagy and mitophagy to AD pathology. From a therapeutic perspective, this review also intends to clarify whether, when, and how autophagy can be targeted to efficaciously counteract AD-related symptomatic and neuropathological features.
    Full-text · Article · Feb 2015 · DNA and Cell Biology
  • Source
    • "These eIF2α kinases activate glycogen synthase kinase-3β (GSK-3β), a major tau kinase, in brain (Baltzis et al., 2007; Bose et al., 2011). Furthermore, there is evidence that PERK and PKR may also facilitate phosphorylation of tau independently of GSK-3β connection in some experimental setting (Azorsa et al., 2010; Ho et al., 2012). Of particular interest, Ho et al. (2012) report that ER stress-related activation of the PERK-eIF2α pathway causes tau phosphorylation, while levels of phosphorylated PERK and eIF2α are increased in response to experimentally induced hyperphosphorylation of tau in primary cortical cultures and TauP301L transgenic mice. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cell signaling in response to an array of diverse stress stimuli converges on the phosphorylation of eukaryotic initiation factor-2α (eIF2α). Evidence is accumulating that persistent eIF2α phosphorylation at Ser51 through prolonged overactivation of regulatory kinases occurs in neurodegenerative diseases such as Alzheimer's disease (AD), leading to shutdown of general translation and translational activation of a subset of mRNAs. Recent advances in the development of gene-based strategies and bioavailable inhibitors, which specifically target one of the eIF2α kinases, have enabled us to investigate pathogenic roles of dysregulated eIF2α phosphorylation pathways. This review provides an overview of animal model studies in this field, focusing particularly on molecular mechanisms by which the dysregulation of eIF2α kinases may account for synaptic and memory deficits associated with AD. A growing body of evidence suggests that correcting aberrant eIF2α kinase activities may serve as disease-modifying therapeutic interventions to treat AD and related cognitive disorders.
    Full-text · Article · Apr 2014 · Frontiers in Molecular Neuroscience
  • Source
    • "The UPR may therefore initiate two key aspects of tau pathology by generating abnormally phosphorylated tau species and promoting tau aggregation. In support of this possibility, Ho et al. (2012) demonstrated tau phosphorylation following UPR activation in primary neuronal cultures from rats. "

    Full-text · Article · Sep 2013 · The Journal of Neuroscience : The Official Journal of the Society for Neuroscience
Show more